Geode Capital Management LLC Lowers Stock Holdings in Electromed, Inc. (NYSE:ELMD)

Geode Capital Management LLC cut its holdings in Electromed, Inc. (NYSE:ELMD) by 2.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 67,874 shares of the company’s stock after selling 1,953 shares during the period. Geode Capital Management LLC owned 0.80% of Electromed worth $1,458,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the business. Barclays PLC acquired a new position in Electromed in the third quarter valued at $215,000. Marshall Wace LLP acquired a new stake in Electromed in the 2nd quarter worth about $256,000. Walleye Capital LLC purchased a new stake in Electromed in the 3rd quarter valued at about $274,000. Navellier & Associates Inc. acquired a new position in shares of Electromed during the 3rd quarter valued at about $368,000. Finally, State Street Corp lifted its holdings in shares of Electromed by 14.5% during the 3rd quarter. State Street Corp now owns 22,066 shares of the company’s stock worth $474,000 after acquiring an additional 2,800 shares during the period. Hedge funds and other institutional investors own 40.82% of the company’s stock.

Electromed Stock Performance

ELMD opened at $31.12 on Thursday. Electromed, Inc. has a 1 year low of $9.90 and a 1 year high of $31.88. The company’s 50 day simple moving average is $28.23 and its 200 day simple moving average is $21.34. The stock has a market capitalization of $263.21 million, a PE ratio of 43.22 and a beta of 0.31.

Electromed (NYSE:ELMD) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.13. The company had revenue of $14.67 million for the quarter. Electromed had a net margin of 11.34% and a return on equity of 15.32%.

Insider Buying and Selling at Electromed

In other news, Director Andrew Summers sold 12,731 shares of the stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $29.98, for a total value of $381,675.38. Following the completion of the sale, the director now owns 165,755 shares of the company’s stock, valued at $4,969,334.90. This represents a 7.13 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 14.00% of the stock is owned by company insiders.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.